Updated Jul 16, 2026
Slaoui Moncef has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
Moncef Slaoui is a Moroccan-born American scientist and biopharmaceutical executive. He is widely known for leading GlaxoSmithKline's vaccines research and development and for serving as a senior advisor to the U.S. government for vaccine development during the COVID-19 era (Operation Warp Speed). As of the June 15, 2026 SEC filing context, he is listed as a Director of Arcturus Therapeutics Holdings Inc.
| Role | Director |
|---|---|
| Notability | 78/100 |
| Links | Wikipedia |
Moncef Slaoui is a Moroccan-born American scientist and biopharmaceutical executive. He is widely known for leading GlaxoSmithKline's vaccines research and development and for serving as a senior advisor to the U.S. government for vaccine development during the COVID-19 era (Operation Warp Speed). As of the June 15, 2026 SEC filing context, he is listed as a Director of Arcturu…
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Slaoui Moncef profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.